Search Results 311-320 of 5591 for albumin

  1. Triple-negative breast cancer patients should undergo genetic screening

    ... . VID-20381079. Home; Triple-negative breast cancer patients should undergo genetic screening. Double your impact on cancer!

  2. Mayo Clinic's mobile exhibit takes to the road to commemorate the 150th anniversary

    ... . VID-20094087. Home; Mayo Clinic's mobile exhibit takes to the road to commemorate the 150th anniversary. Double your impact on cancer!

  3. Publications - Ming Yang, M.D. - Mayo Clinic

    99mTc-Macroaggregated Albumin SPECT/CT Perfusion Imaging of Omental Extrahepatic Vascularization. Clin Nucl Med. 2016 Jan; 41: (1)e56-e57. View PubMed ...

  4. A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    These patients are at high risk for progression of kidney disease, which can result in end-stage renal failure. Participation eligibility. Participant ...

  5. Mayo Clinic

    ... . IMG-20075901. Home; florida-8col. Double your impact on cancer! Give Now. Make a gift before July 31 and it can be doubled in impact thanks to a ...

  6. Drugs and Supplements that Start with B - Mayo Clinic

    Albumin human (intravenous route). Buphenyl. Also known as. Sodium phenylbutyrate (oral route) · Bupivacaine (implantation route) · Bupivacaine (injection route).

  7. Gastro Hepatology - Mayo Clinic

    Double your impact on cancer! ... Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge. Give Now.

  8. A pivotal study of derazantinib in patients with inoperable or advanced intrahepatic cholangiocarcinoma and FGFR2 gene fusions or FGFR2 gene mutations or amplifications - Mayo Clinic

    Albumin ≥ 2.8 g/dL. Renal. Serum creatinine ≤ 1.5 × ULN; or; Creatinine clearance of ≥ 30 mL/min as estimated by the Cockcroft-Gault equation. Female and ...

  9. Heart Valve Surgery Clinical Trials - Mayo Clinic Research

    The purpose of this study is to compare the total fluid volume of using 5% human albumin and Lactated Ringer's in the perioperative cardiac surgical patient.

  10. A study to test whether survodutide helps people with a liver disease called NASH/MASH who have cirrhosis - Mayo Clinic

    Participation eligibility · Albumin below < 3 . · INR > 1.3 unless due to therapeutic anticoagulants NOTE: INR may be repeated once to reassess eligibility.